RPRX - Royalty Pharma Plc - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

RPRX is currently covered by 8 analysts with an average price target of $43.51. This is a potential upside of $14.27 (48.8%) from yesterday's end of day stock price of $29.24.

Royalty Pharma Plc's activity chart (see below) currently has 10 price targets and 33 ratings on display. The stock rating distribution of RPRX is 95.83% BUY and 4.17% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 1.01% with an average time for these price targets to be met of 19.89 days.

Highest price target for RPRX is $57, Lowest price target is $41, average price target is $43.51.

Most recent stock forecast was given by CHRIS SCHOTT from JPMORGAN on 20-Feb-2024.

Currently out of the existing stock ratings of RPRX, 23 are a BUY (95.83%), 1 are a SELL (4.17%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

42

$12.76 (43.64%)

49

1 months 23 days ago

0/5 (0%)

$11.7 (38.61%)

Buy

50

$20.76 (71.00%)

60

1 months 23 days ago

0/3 (0%)

$19.7 (65.02%)

Buy

57

$27.76 (94.94%)

54

5 months 3 days ago

1/11 (9.09%)

$29.99 (111.03%)

179

Buy

41

$11.76 (40.22%)

44

8 months 3 days ago

0/4 (0%)

$11.1 (37.12%)

Buy

60

$30.76 (105.20%)

50

1 years 8 months 15 days ago

0/3 (0%)

$18.17 (43.44%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RPRX (Royalty Pharma Plc) average time for price targets to be met?

On average it took 19.89 days on average for the stock forecasts to be realized with a an average price target met ratio 1.01

Which analyst has the current highest performing score on RPRX (Royalty Pharma Plc) with a proven track record?

NAVIN JACOB

Which analyst has the current lower performing score on RPRX (Royalty Pharma Plc) with a proven track record?

UMER RAFFAT

Which analyst has the most public recommendations on RPRX (Royalty Pharma Plc)?

Navin Jacob has 13 price targets and 7 ratings on RPRX

Which analyst is the currently most bullish on RPRX (Royalty Pharma Plc)?

Andrew Baum with highest potential upside - $30.76

Which analyst is the currently most reserved on RPRX (Royalty Pharma Plc)?

Umer Raffat with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?